author-photo

Julie L.C. Kan

Pfizer

11

Papers

400

Citations

Citation Trend

Filter By

Papers (7) Sort By

Journal Conference Others

Abstract LB-136: Mechanistic exploration of combined CDK4/6 and ER inhibition in ER-positive breast cancer

2014 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Tumor P-Glycoprotein Correlates with Efficacy of PF-3758309 in in vitro and in vivo Models of Colorectal Cancer

2013 Frontiers in Pharmacology
Show All
- Source
- Cite
- Save
Citations (26)
Molecular Predictors of Sensitivity to the Insulin-like Growth Factor 1 Receptor Inhibitor Figitumumab (CP-751,871)

2013 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (23)
Development of a Colon Cancer GEMM-Derived Orthotopic Transplant Model for Drug Discovery and Validation

2013 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (30)
An integrated genomic approach to identify predictive biomarkers of response to the aurora kinase inhibitor PF-03814735.

2012 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (75)
Abstract 5063: Preclinical evaluation of an EMT multi-gene biomarker index for predicting response to inhibitors of EGFR and IGF1R

2011 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract LB-302: Activity of PF-04691502, A dual PI3K/mTOR inhibitor in breast cancer cell lines and models discriminates between ER, PR and HER2 positive and negative segments

2010 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)